As the life sciences sector continues to experience rapid growth, so does the number of related arbitrations. Many pharma and biotech projects are highly complex, span many years and involve numerous stakeholders, providing fertile ground for disputes. The panel will showcase why international arbitration is well suited to resolve licensing, joint-venture, and co-marketing disagreements that accompany these projects. Other speakers include Preeti Bhagnani, Partner, White & Case; and Daniel Weiner, Partner, Hughes Hubbard & Reed.